Dr. Ryan D. Cassaday
Claim this profileFred Hutchinson Cancer Research Center
Studies Childhood Cancer
Studies Lymphoma
3 reported clinical trials
9 drugs studied
Area of expertise
1Childhood Cancer
CD19 positive
Ph negative
2Lymphoma
CD19 positive
Ph negative
Affiliated Hospitals
Clinical Trials Ryan D. Cassaday is currently running
Chemotherapy + Targeted Therapy
for Acute Lymphoblastic Leukemia
This phase II clinical trial tests a chemotherapy regimen (dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin with or without rituximab \[DA-EPOCH+/-R\]) with the addition of targeted therapy (tafasitamab) for the treatment of patients with newly diagnosed Philadelphia chromosome negative (Ph-) B acute lymphoblastic leukemia (B-ALL). Chemotherapy drugs, such as those in EPOCH+/-R, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Tafasitamab is in a class of medications called monoclonal antibodies. It works by helping the body to slow or stop the growth of cancer cells. Adding tafasitamab to the DA-EPOCH+/-R regimen may work better than DA-EPOCH+/-R alone in treating newly diagnosed Ph- B-ALL.
Recruiting2 awards Phase 2
OBI-3424
for T-Cell Acute Lymphoblastic Leukemia
This phase II trial studies how well OBI-3424 works in treating patients with T-cell acute lymphoblastic leukemia that has come back (relapsed) or does not response to treatment (refractory). Drugs used in chemotherapy, such as OBI-3424, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. OBI-3424 may reduce the amount of leukemia in the body.
Recruiting1 award Phase 219 criteria
More about Ryan D. Cassaday
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Ryan D. Cassaday has experience with
- Doxorubicin
- Prednisone
- Asparaginase Erwinia Chrysanthemi
- Rituximab
- Cyclophosphamide
- Etoposide
Breakdown of trials Ryan D. Cassaday has run
Childhood Cancer
Lymphoma
Acute Lymphoblastic Leukemia
T-Cell Lymphoblastic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ryan D. Cassaday specialize in?
Ryan D. Cassaday focuses on Childhood Cancer and Lymphoma. In particular, much of their work with Childhood Cancer has involved CD19 positive patients, or patients who are Ph negative.
Is Ryan D. Cassaday currently recruiting for clinical trials?
Yes, Ryan D. Cassaday is currently recruiting for 2 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Ryan D. Cassaday has studied deeply?
Yes, Ryan D. Cassaday has studied treatments such as Doxorubicin, Prednisone, Asparaginase Erwinia chrysanthemi.
What is the best way to schedule an appointment with Ryan D. Cassaday?
Apply for one of the trials that Ryan D. Cassaday is conducting.
What is the office address of Ryan D. Cassaday?
The office of Ryan D. Cassaday is located at: Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 United States. This is the address for their practice at the Fred Hutchinson Cancer Research Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.